106 related articles for article (PubMed ID: 8081715)
1. Novel adenosine receptor ligands: 1,3-disubstituted[1]benzopyrano[2,3-c]pyrazol-4-ones. Synthesis and structure-activity relationships.
Colotta V; Cecchi L; Catarzi D; Melani F; Filacchioni G; Martini C; Tacchi P; Lucacchini A
Recept Channels; 1993; 1(2):111-9. PubMed ID: 8081715
[TBL] [Abstract][Full Text] [Related]
2. Tricyclic heteroaromatic systems. Synthesis and A1 and A2a adenosine binding activities of some 1-aryl-1,4-dihydro-3-methyl[1]benzopyrano[2,3-c] pyrazol-4-ones, 1-aryl-4,9-dihydro-3-methyl-1H-pyrazolo[3,4-b]quinolin-4- ones, and 1-aryl-1H-imidazo[4,5-b]quinoxalines.
Catarzi D; Cecchi L; Colotta V; Filacchioni G; Martini C; Tacchi P; Lucacchini A
J Med Chem; 1995 Apr; 38(8):1330-6. PubMed ID: 7731018
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and A1 and A2A adenosine binding activity of some pyrano[2,3-c]pyrazol-4-ones.
Colotta V; Catarzi D; Varano F; Melani F; Filacchioni G; Cecchi L; Trincavelli L; Martini C; Lucacchini A
Farmaco; 1998 Mar; 53(3):189-96. PubMed ID: 9639867
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists.
Baraldi PG; Cacciari B; Spalluto G; Bergonzoni M; Dionisotti S; Ongini E; Varani K; Borea PA
J Med Chem; 1998 Jun; 41(12):2126-33. PubMed ID: 9622554
[TBL] [Abstract][Full Text] [Related]
5. Tricyclic heteroaromatic systems: [1]benzopyrano-pyrazol-4-ones as benzodiazepine receptor ligands.
Colotta V; Cecchi L; Melani F; Filacchioni G; Martini C; Gelli S; Lucacchini A
J Pharm Sci; 1991 Mar; 80(3):276-9. PubMed ID: 1646879
[TBL] [Abstract][Full Text] [Related]
6. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists.
Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Klotz KN; Leung E; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 1999 Nov; 42(22):4473-8. PubMed ID: 10579811
[No Abstract] [Full Text] [Related]
7. Structure-activity relationships in a series of 8-substituted xanthines as A1-adenosine receptor antagonists.
Strappaghetti G; Corsano S; Barbaro R; Giannaccini G; Betti L
Bioorg Med Chem; 2001 Mar; 9(3):575-83. PubMed ID: 11310591
[TBL] [Abstract][Full Text] [Related]
8. 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
Sarges R; Howard HR; Browne RG; Lebel LA; Seymour PA; Koe BK
J Med Chem; 1990 Aug; 33(8):2240-54. PubMed ID: 2374150
[TBL] [Abstract][Full Text] [Related]
9. 1,2,4-Triazolo[4,3-a]quinoxalin-1-one: a versatile tool for the synthesis of potent and selective adenosine receptor antagonists.
Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
J Med Chem; 2000 Mar; 43(6):1158-64. PubMed ID: 10737748
[TBL] [Abstract][Full Text] [Related]
10. High-pressure synthesis of enantiomerically pure C-6 substituted pyrazol.
Poulsen SA; Young DJ; Quinn RJ
Bioorg Med Chem Lett; 2001 Jan; 11(2):191-3. PubMed ID: 11206456
[TBL] [Abstract][Full Text] [Related]
11. Further characterization of [3H]-CGS 21680 binding sites in the rat striatum and cortex.
Kirk IP; Richardson PJ
Br J Pharmacol; 1995 Jan; 114(2):537-43. PubMed ID: 7881753
[TBL] [Abstract][Full Text] [Related]
12. Doridosine derivatives: binding at adenosine receptors and in vivo effects.
Tao PL; Yen MH; Shyu WS; Chern JW
Eur J Pharmacol; 1993 Oct; 243(2):135-9. PubMed ID: 8276062
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of a new set of 2-arylpyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists.
Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
J Med Chem; 2000 Aug; 43(16):3118-24. PubMed ID: 10956220
[TBL] [Abstract][Full Text] [Related]
14. Tricyclic heteroaromatic systems. Synthesis of 1,3 and 1,2 disubstituted [1]benzopyrano[4,3-b]pyrrol-4-ones and structure-activity relationships as benzodiazepine receptor ligands.
Colotta V; Cecchi L; Melani F; Filacchioni G; Martini C; Gelli S; Lucacchini A
Farmaco; 1991 Oct; 46(10):1139-54. PubMed ID: 1667727
[TBL] [Abstract][Full Text] [Related]
15. Relative binding orientations of adenosine A1 receptor ligands--a test case for Distributed Multipole Analysis in medicinal chemistry.
van der Wenden EM; Price SL; Apaya RP; IJzerman AP; Soudijn W
J Comput Aided Mol Des; 1995 Feb; 9(1):44-54. PubMed ID: 7751869
[TBL] [Abstract][Full Text] [Related]
16. 2-Aryl-8-azaadenosines: structure-activity relationships in the binding with A1 and A2 receptors. A comparison with the corresponding 9-benzyl-8-azaadenines. III.
Biagi G; Giorgi I; Livi O; Scartoni V; Lucacchini A; Martini C; Tacchi P
Farmaco; 1994 Feb; 49(2):93-6. PubMed ID: 8003186
[TBL] [Abstract][Full Text] [Related]
17. N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor.
van Tilburg EW; von Frijtag Drabbe Künzel J; de Groote M; Vollinga RC; Lorenzen A; IJzerman AP
J Med Chem; 1999 Apr; 42(8):1393-400. PubMed ID: 10212125
[TBL] [Abstract][Full Text] [Related]
18. Further characterization of a CNS adenosine A2a receptor ligand [11C]KF18446 with in vitro autoradiography and in vivo tissue uptake.
Ishiwata K; Ogi N; Shimada J; Nonaka H; Tanaka A; Suzuki F; Senda M
Ann Nucl Med; 2000 Apr; 14(2):81-9. PubMed ID: 10830524
[TBL] [Abstract][Full Text] [Related]
19. A novel class of adenosine A3 receptor ligands. 1. 3-(2-Pyridinyl)isoquinoline derivatives.
van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; IJzerman AP
J Med Chem; 1998 Oct; 41(21):3987-93. PubMed ID: 9767636
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationship of pyrazolo[3,4-d]pyrimidines: potent and selective adenosine A1 receptor antagonists.
Poulsen SA; Quinn RJ
J Med Chem; 1996 Oct; 39(21):4156-61. PubMed ID: 8863792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
